Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00026780 : Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
AgesMin: 1 Month Max: N/A

Children and young adults who are being evaluated for and treated on protocols within the
Pediatric Oncology Branch.

All patients or their legal guardians (if the patient is less than 18 years of age) must
sign a document of informed consent indicating their understanding of the research nature
and the risks of the procedures that will be performed to assess eligibility for primary
research protocols. When appropriate, pediatric patients (less than 18 years of age) will
be included in all discussions in order to obtain verbal assent.

Patients or their parents/guardians can refuse to participate in the tissue procurement
portion of this protocol and still participate in the screening for eligibility on POB
research trials.

A Durable Power of Attorney (DPA) will be offered to all patients greater than or equal to
18 years of age who have a brain tumor or meningeal tumor involvement.


LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557